Vu Tran
Sleep Medicine · Santa Rosa, CANPI 1528021490
Payments from drug & device makers
Across 922 payments — averaging $28.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$5K
- GSK$5K
- Philips North America LLC$4K
- Boehringer Ingelheim$3K
- Sanofi$2K
- Apria Healthcare LLC$1K
- plus $6K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 206 | $5,194 |
| GSK | 227 | $4,561 |
| Philips North America LLC | 45 | $3,711 |
| Boehringer Ingelheim | 136 | $3,456 |
| Sanofi | 80 | $2,113 |
| Apria Healthcare LLC | 3 | $1,380 |
| Regeneron Healthcare Solutions, Inc. | 33 | $1,136 |
| Harmony Biosciences LLC | 22 | $658 |
| Baxter Healthcare | 27 | $478 |
| Amgen | 17 | $445 |
| Sanofi-aventis U.S. LLC | 6 | $403 |
| Grifols USA, LLC | 18 | $380 |
| Novartis | 11 | $259 |
| Verona Pharma, Inc. | 9 | $221 |
| Electromed, Inc. | 11 | $208 |
| Hologic Inc | 1 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $192 |
| Lilly USA, LLC | 8 | $173 |
| Genentech USA, Inc. | 7 | $161 |
| Noctrix Health, Inc. | 1 | $149 |
| Insmed, Inc. | 5 | $135 |
| Inspire Medical Systems, Inc. | 4 | $134 |
| Mallinckrodt Hospital Products Inc. | 6 | $133 |
| AbbVie | 1 | $125 |
| CSL Behring | 6 | $118 |
| Advanced Respiratory, Inc | 5 | $104 |
| Jazz Pharmaceuticals Inc. | 4 | $92 |
| Resmed Corp | 3 | $76 |
| Shire North American Group Inc | 3 | $72 |
| United Therapeutics Corporation | 3 | $68 |
| Johnson & Johnson | 1 | $24 |
| Merck | 1 | $24 |
| Avanir Pharmaceuticals, Inc. | 1 | $24 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $18 |
| Genentech, Inc. | 1 | $18 |
| Mylan Specialty L.p. | 1 | $17 |
| Fisher & Paykel Healthcare Inc | 1 | $15 |
How this compares
$26,670 in reported general payments places this provider in the 90th percentile of 200 sleep medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other sleep medicine in Santa Rosa
- Emmanuel MignotStanford$4.7M
- Daniel NormanLos Angeles$4.2M
- Atul MalhotraSan Diego$1.4M
- Lisa ShivesSan Diego$1.4M
- Haramandeep SinghSan Ramon$1.3M
- Logan SchneiderStanford$506K
- Tony MasriLos Gatos$327K
- Clete KushidaStanford$231K
- Sam KashaniSanta Monica$221K
- Makoto KawaiPalo Alto$141K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.